Top Tweets for #oncoresponse
PRESS RELEASE: #OncoResponse Announces Phase 1 Results of Clinical Trial of #OR502, anti-LILRB2 Antibody, in Subjects with Advanced Cancer. Results available in Late-Breaking Poster Presentation at SITC 2024. See the full release: https://t.co/hS2l82iqYU #EliteCancerResponders

PRESS RELEASE: #OncoResponse to Present Phase 1 Results of Clinical Study of #OR502, anti-LILRB2 Antibody, at SITC 2024. See the full release here: https://t.co/uUiIJ92J48 #EliteCancerResponders

#OncoResponse CEO @CliffordStocks will be giving a company presentation at @LifeScienceWA's Life Science Innovation Northwest 2024 in Seattle this week
#EliteCancerResponders #LSINW24

PRESS RELEASE: #OncoResponse Announces Initiation of Phase 1/2 Clinical Trial of #OR502, anti-LILRB2 Antibody, in Subjects with Advanced Cancer. See the full release here: https://t.co/NPfxjABIrc
#EliteCancerResponders

PRESS RELEASE: #OncoResponse Announces Preclinical Data Highlighting #OR502 anti-LILRB2 Antibody and #OR641 Dual anti-LILRB2/1 Antibody at SITC 2023 #SITC23 #EliteCancerResponders Posters available now: https://t.co/FvL6bRjrss
https://t.co/uTYy6vZKKw
#OncoResponse Raises $14 Million in Added Funds from Investors to Advance Cancer Immunotherapy. Led by @RiverVest and including ARCH Venture Partners, @canaanpartners, 3B Future Health Fund, Bering Capital, @TakedaPharma Ventures, InterVest, and others. #EliteCancerResponders

OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer Responders, today announced it has raised $14M in funding.
https://t.co/rKb89o3Gp6
#OncoResponse #biotechnology #chatgptai #medtechproblems

#OncoResponse awarded $13 million @CPRITTexas grant to fund the advancement of OR502, a best-in-class anti-LILRB2 antibody poised to move to IND and clinical studies. #EliteCancerResponders
https://t.co/6xFIW27kut
#OncoResponse CEO @CliffordStocks presents today at #LSINW23 (@LifeScienceWA), representing OncoResponse during company presentations on Oncology & Rare Disease. Other companies include @UmojaBiopharma,@CartographyBio,@PresageBio,@ChinookTx,and @kayothera. #EliteCancerResponders

#OncoResponse CEO @CliffordStocks will be presenting at #LSINW23 (@LifeScienceWA) on April 25th, representing OncoResponse during company presentations on Oncology & Rare Disease. Other companies include @UmojaBiopharma, @CartographyBio, @PresageBio, @ChinookTx, and @kayothera.

We are now two weeks away from presenting at #AACR2023! #OncoResponse's poster will publicly introduce for the first time our preclinical data of dual-targeting antibodies for LILRB1 and LILRB2. The poster presentation will take place April 19th. @AACR #EliteCancerResponders

#OncoResponse's Kamal Puri, PhD, is presenting today at the 2023 Festival of Biologics Conference. Dr. Puri will discuss our novel platform and technology, as well as our anti-CD163 clinical-stage antibody OR2805 and anti-LILRB2/ILT4 antibody OR502. #EliteCancerResponders

Happy New Year! Hello 2023!
Thank you for following #OncoResponse and joining us on our journey developing novel immunotherapies. We look forward to sharing further advancements with you in this exciting new year. #EliteCancerResponders

Very much looking forward to visiting NYC to present OncoResponse's exciting advancements, meet with new investors and partners, and say hello to friends and colleagues not seen since Covid. DM me if you want to set a meeting Wednesday or Thursday.#OncoResponse #PSCHealthcare2022
#OncoResponse is looking forward to participating in @PiperSandler's 34th Annual Healthcare Conference. Nov. 30th, 3:30-3:50pm EST, CEO @CliffordStocks will present data on antibodies OR2805 and OR502 and discuss OncoResponse's platform. #PSCHealthcare2022 #EliteCancerResponder

#OncoResponse is looking forward to participating in @PiperSandler's 34th Annual Healthcare Conference. Nov. 30th, 3:30-3:50pm EST, CEO @CliffordStocks will present data on antibodies OR2805 and OR502 and discuss OncoResponse's platform. #PSCHealthcare2022 #EliteCancerResponder

#OncoResponse is looking forward to participating in @PiperSandler's 34th Annual Healthcare Conference. Nov. 30th, 3:30-3:50pm EST, CEO @CliffordStocks will present data on antibodies OR2805 and OR502 and discuss OncoResponse's platform. #PSCHealthcare2022 #EliteCancerResponders
#OncoResponse today announced the preclinical data on immuno-oncology candidates #OR2805 and #OR502 presented at the @sitcancer 37th Annual Meeting. The posters are now on our website: https://t.co/FvL6bRjrss
#SITC2022 #EliteCancerResponders
https://t.co/tr6uvvw65Q
#OncoResponse will be presenting posters at the #SITC2022 37th Annual Meeting in Boston, MA.
Abstract #39: Thursday, 11/10/22, 9am-9pm EST;
Abstract #498: Friday, 11/11/22, 9am-8:30pm EST
Posters will be available online the day before the presentation.
https://t.co/OUO0CrQGyE
#OncoResponse Senior Director of Immuno-Oncology, Peter Probst, PhD, will present at the Immuno-Oncology Summit in Boston, MA on October 13th, 2022, discussing our clinical-stage anti-CD163 antibody #OR2805 and preclinical LILRB2/ILT4 antibody. #IOSummit
https://t.co/094UWxmezm

PRESS RELEASE: #OncoResponse announces a clinical supply agreement with @Regeneron to evaluate our lead antibody #OR2805 in combination with the PD-1 inhibitor Libtayoยฎ (cemiplimab) in patients with advanced cancer.
https://t.co/p4XvlJ7R3b
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers


